Everyday Use & Best Practices

Basic Efavirenz Information

• INN (International Nonproprietary Name): Efavirenz
• Brand Names Available In United States: Sustiva, Atripla, Symfi (combination)
• ATC Code: J05AG03
• Forms & Dosages: Tablets 600 mg and 200 mg; capsules 50 mg (pediatric) and 200 mg
• Manufacturers In United States: Bristol-Myers Squibb (originator), generics by Teva, Mylan, Sandoz, and others
• Registration Status In United States: Approved by FDA since 1998
• OTC / Rx Classification: Prescription only (Rx)

Morning Vs Evening Dosing

How do I pick the best time for Efavirenz each day?

Take efavirenz 600 mg once daily as the usual adult dose to build a consistent routine.

Many patients find evening dosing helps reduce daytime dizziness and vivid dreams.

If central nervous system effects such as insomnia, vivid dreams, or dizziness occur, consider switching to a bedtime dose and monitor for daytime drowsiness.

For shift workers or people with unpredictable sleep, choose a consistent clock time (for example, 10 PM) and set alarms to keep adherence steady.

• Checklist For A Dosing Routine
• Take Efavirenz 600 mg once daily at the same time every day.
• Use a pillbox or phone alarm to build the habit.
• Prefer evening dosing if you experience daytime dizziness or vivid dreams.
• Do not stop or skip doses without consulting your provider; stopping can risk resistance because efavirenz is always used as part of combination ART.

• If You Experience
• Insomnia or vivid dreams: try taking near bedtime and discuss with your clinician.
• Excessive daytime drowsiness: consider moving the dose earlier or reevaluating regimen with your clinician.
• Persistent mood changes: contact your clinician right away.

Taking With Or Without Meals

Does food matter when taking Efavirenz?

Follow label instructions and take efavirenz with or after food to match clinical guidance.

Many clinicians advise taking it with a light snack to reduce stomach upset while keeping absorption consistent day to day.

Be aware that very high-fat meals may alter absorption and could enhance side effects; ask your clinician if you have questions about meal composition.

Consistency is the key: take efavirenz with similar meals each day so exposure remains predictable.

Safety Priorities

Who Should Avoid It

Who should not take Efavirenz?

Do not take efavirenz if you have known hypersensitivity to efavirenz or any formulation component.

Avoid efavirenz in severe hepatic impairment; it is an absolute contraindication.

Avoid coadministration with certain drugs such as voriconazole, elbasvir/grazoprevir, St. John’s Wort, some benzodiazepines, and ergot derivatives.

Use caution if you have a history of psychiatric illness like depression or psychosis because efavirenz commonly causes central nervous system side effects and may worsen these conditions.

Exercise caution if you have seizures or a seizure disorder because CNS events can be provoked.

Women of childbearing potential should discuss contraception because of teratogenic risk and consider alternatives when pregnancy is planned.

• Do Not Take If...
• You have known hypersensitivity to efavirenz or formulation ingredients.
• You have severe hepatic impairment.
• You are taking contraindicated drugs such as voriconazole, elbasvir/grazoprevir, or St. John’s Wort.

Activities To Limit

Which daily activities require caution while starting Efavirenz?

Avoid driving, operating heavy machinery, or other tasks requiring alertness until you know how efavirenz affects you.

Limit heavy alcohol use, especially during the first weeks of therapy, because alcohol can worsen dizziness and drowsiness.

If you have a seizure disorder, ensure optimal seizure control and inform your clinician before starting efavirenz.

Dosage & Adjustments

General Regimen

What is the standard dosing for adults?

The usual adult dose is 600 mg once daily as part of combination antiretroviral therapy.

Efavirenz should never be used as monotherapy because that leads to resistance.

WHO defined daily dose (DDD) is 0.6 g orally per day.

For post-exposure prophylaxis, efavirenz 600 mg daily is used in combination regimens for approximately 28 days.

Special Cases

How is dosing adjusted for children, elderly, liver, and kidney disease?

Children dosing is weight-based; children weighing 35 kg or more typically receive 600 mg once daily.

Younger children or lower weight bands receive 200 mg or 300 mg tablets or 50 mg capsules as appropriate.

For elderly patients, start at the standard dose but monitor closely because pharmacokinetics are not fully evaluated.

Avoid efavirenz in moderate to severe hepatic impairment; use caution and monitor liver enzymes in mild dysfunction.

No dose adjustment is required for mild to moderate renal impairment, but avoid use in severe renal disease due to limited data.

• Monitoring & When To Call
• Call the clinic for severe rash, new or worsening psychiatric symptoms, seizures, or jaundice.
• Contact your provider for persistent vomiting that prevents taking medication or suspected drug interactions.

User Testimonials

Positive Reports

What do patients like about Efavirenz?

Many patients report once-daily dosing and availability in fixed-dose combinations such as Atripla or Symfi make adherence easier.

Users often appreciate fewer pills when efavirenz is part of a fixed-dose combo and report effective viral suppression when taken correctly as part of combination ART.

Generics from Teva, Mylan, Sandoz, and others improve access and reduce cost for many patients.

• "Once-a-day was simple and helped me keep up with my treatment."
• "Switching to a fixed-dose combo cut my pill burden in half."
• "Generic options made the medication affordable when I had high copays."

Common Challenges

What problems do patients commonly report?

CNS side effects such as insomnia, vivid dreams, dizziness, and impaired concentration are the most frequently reported issues.

Some patients describe GI upset and rashes early in therapy, and a subset experiences mood changes that require switching drugs.

Because guidelines increasingly favor integrase inhibitors like dolutegravir, some people report switching due to tolerability even though efavirenz remains effective.

• Coping Strategies
• Practice sleep hygiene and take efavirenz at bedtime if vivid dreams or insomnia occur.
• Report mood changes early so your clinician can assess and, if needed, change therapy.
• Use fixed-dose combinations to improve adherence and reduce pill burden.

Buying Guide

Pharmacy Sources

Where can you get Efavirenz in the United States?

Efavirenz is prescription-only in the US and can be filled at local pharmacies or accredited online pharmacies.

Brand names include Sustiva and fixed-dose combinations like Atripla and Symfi, while generics are supplied by Teva, Mylan, Sandoz, and others.

Check insurer formularies for preferred generics and explore manufacturer patient assistance programs for brand products from BMS or Gilead.

In our online pharmacy, Efavirenz is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

How do you compare costs and verify authenticity?

Compare copays, manufacturer coupons, and patient assistance programs to lower out-of-pocket costs.

Generics from Teva, Mylan, and Sandoz are generally less expensive than brand products.

When sourcing internationally, verify packaging, tablet strengths, and regulatory approval to ensure authenticity.

Avoid unverified online sellers; look for prescription verification, pharmacy accreditation, and intact original packaging as signs of legitimacy.

What’s Inside & How It Works

Ingredients Overview

What formulations and combinations are available?

Efavirenz monotherapy tablets commonly come in 600 mg and 200 mg strengths.

Pediatric capsules are available in 50 mg and 200 mg forms for weight-based dosing.

Fixed-dose combinations include efavirenz plus emtricitabine and tenofovir, for example Atripla which combines EFV 600 mg, FTC 200 mg, and TDF 300 mg.

Generics are marketed by Teva, Mylan, Zentiva, Sandoz, Krka, and others.

Mechanism Basics

How does Efavirenz stop HIV?

Efavirenz is a non-nucleoside reverse transcriptase inhibitor, or NNRTI.

It binds HIV-1 reverse transcriptase at a nonactive site and causes a conformational change that inhibits viral DNA synthesis.

By reducing viral replication, efavirenz helps control HIV when combined with other antiretrovirals.

The drug must be used as part of combination ART because monotherapy leads to resistance.

Main Indications

Approved Uses

What is Efavirenz officially approved for?

Efavirenz is approved for the management of HIV-1 infection as part of combination antiretroviral therapy.

The typical adult dosing is 600 mg once daily with or after food.

Efavirenz is also used in combination regimens for post-exposure prophylaxis for about 28 days.

It is listed on the WHO Model List of Essential Medicines and is widely registered globally.

Off-Label Uses

Are there other situations where Efavirenz is used?

Some clinicians have used efavirenz in specific resistance scenarios or when alternative agents are not available in resource-limited settings.

However, many guidelines now favor integrase inhibitors such as dolutegravir as first-line due to better tolerability and fewer CNS effects.

Interaction Warnings

Food Interactions

Does food change Efavirenz activity?

Efavirenz is recommended to be taken with or after food, and consistency is important for absorption.

Taking efavirenz with a light snack can reduce stomach upset while keeping exposure steady.

Avoid unusually high-fat meals without clinical advice because absorption may be altered and side effects could be enhanced.

Drug Conflicts

What drugs should not be mixed with Efavirenz?

Efavirenz affects cytochrome P450 enzymes and has clinically important interactions.

Avoid coadministration with voriconazole and elbasvir/grazoprevir, and do not use St. John’s Wort due to loss of antiviral effect.

Certain benzodiazepines and ergot derivatives are contraindicated or should be used only with caution.

Efavirenz can reduce the effectiveness of some hormonal contraceptives, so discuss alternative contraception or dose adjustments with your clinician.

• Always present a current medication list to any prescribing clinician.
• Check new medications with your HIV clinician or pharmacist before starting them.

Latest Evidence & Insights

Clinical Trends

How has Efavirenz’s role changed over time?

Efavirenz was approved by the FDA in 1998 and by the EMA in 1999 and remains on WHO’s Model List of Essential Medicines.

Global guidance has shifted toward integrase inhibitors such as dolutegravir for many first-line regimens because of improved tolerability and fewer CNS adverse effects.

Despite that, efavirenz remains effective, widely available, and an important option in many settings, especially where generics increase access.

Safety Updates

What safety issues should clinicians and patients watch for?

Ongoing evidence emphasizes monitoring neuropsychiatric side effects and liver enzymes during therapy.

Reported teratogenic risk in pregnancy has led to cautious use in women of childbearing potential and to counseling about contraception and alternatives.

Severe dermatological reactions like Stevens–Johnson syndrome are rare but require immediate clinical attention.

• Timeline: FDA approval 1998; EMA approval 1999; listed on WHO essential medicines list.
• Guidelines: increasing preference for dolutegravir-based regimens in many national protocols.
• Monitoring: mental health screening and liver function tests during early therapy.

Alternative Choices

Comparable NNRTIs

What other NNRTIs might be considered?

Alternatives in the NNRTI class include nevirapine, rilpivirine, and etravirine.

Each has its own interaction and toxicity profile and may be better tolerated for some patients who experience efavirenz-related CNS effects.

Newer Preferred Agents

Which newer drugs are commonly preferred now?

Integrase inhibitors such as dolutegravir and bictegravir have become first-line choices in many settings because of superior tolerability and a higher barrier to resistance.

Fixed-dose combinations that pair an integrase inhibitor with emtricitabine and tenofovir often replace efavirenz-based combos in modern treatment guidelines.

Regulation Snapshot

Approvals & Listings

What is Efavirenz’s regulatory status?

Efavirenz has FDA approval since 1998 and EMA approval since 1999 and is listed on the WHO Model List of Essential Medicines.

Multiple generics are WHO-prequalified and the medicine is registered and marketed globally.

Packaging & Availability

What strengths and packaging are commonly found?

Common tablet strengths are 600 mg and 200 mg with pediatric capsules of 50 mg available for weight-based dosing.

Packaging is typically blister packs or bottles from manufacturers such as Teva, Mylan, Zentiva, Sandoz, Krka, and the originator Bristol-Myers Squibb.

FAQ Section

Common Quick Answers

• Missed Dose: Take as soon as remembered; if it is close to the next scheduled dose, skip the missed dose and continue.
• Overdose: May cause severe CNS effects such as confusion and hallucinations; supportive care is recommended and activated charcoal may be considered for recent ingestion.
• Storage: Store below 30°C (86°F) and protect from moisture and light.
• Pregnancy: Discuss risks with your clinician; effective contraception is advised and alternatives may be preferred in women planning pregnancy.

When To Call Your Clinician

• Call for severe rash, new or worsening psychiatric symptoms, seizures, jaundice, or signs of liver dysfunction.
• Call if vomiting prevents medication intake or if you suspect a serious drug interaction after starting a new medicine.
• Report persistent dizziness or changes in mood or behavior promptly.

Guidelines For Proper Use

Adherence Checklist

How to stay on track with Efavirenz therapy?

• Take efavirenz 600 mg once daily at the same time each day.
• Use fixed-dose combinations when possible to reduce pill burden, such as Atripla or Symfi.
• Keep a pillbox, set alarms, or enroll in adherence support programs.
• Verify insurance coverage and explore assistance programs for generics by Teva, Mylan, or Sandoz.
• Never use efavirenz alone—always as part of combination ART.

Monitoring & Reporting

What tests and follow-up are recommended?

Obtain baseline and periodic liver function tests and lipid panels.

Institute mental health screening at baseline and during early therapy.

Report CNS symptoms, mood changes, rash, or signs of hepatic dysfunction promptly.

For women of childbearing potential, confirm effective contraception and discuss pregnancy plans before starting efavirenz.

Delivery Across United States